Search Results
Fact Sheet
En la actualidad, la terapia génica para la enfermedad de células falciformes se considera experimental y solo está a su disposición si participa en un estudio clÃnico.
Diversity in the Genomics Workforce
The Training, Diversity, and Health Equity (TiDHE) office along with other NHGRI colleagues have developed the Identifying and Evaluating Trainee Outcomes Toolkit to help programs from all over the country learn more about best practices for evaluating training programs related to genomic workforce diversity, research, and genomic workforce programs.
Fact Sheet
Actualmente, existen diferentes enfoques de terapia génica disponibles a través de ensayos clÃnicos.
Fact Sheet
Diversos enfoques se dirigen a las células madre sanguÃneas para aliviar o reducir los sÃntomas de la anemia de células falciformes.
FAQ
On September 6, 2023, the National Human Genome Research Institute hosted a pre-application webinar for the genomics-enabled learning health systems (gLHS) NOFOs: RFA-HG-23-041 and RFA-HG-23-042. Questions were answered during the webinar.
Fact Sheet
Comprender la terapia génica para la enfermedad de células falciformes
Profile
Dr. Pavan looks back on his career at NHGRI, highlights pivotal moments and shares his future plans in artistic woodworking and community mediation.
Event
NHGRI will host a director's research seminar by Matt Hurles, Director of the Wellcome Trust Sanger Institute on October 30, 2023.
Event
On November 1-5, 2023, the National Human Genome Research Institute (NHGRI) will participate in the ASHG Annual Meeting - the world's largest human genetics and genomics meeting and exposition.  The annual meeting provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics.Â
Profile
In an interview, Boyer reflects on her NHGRI career, the history of the NHGRI ELSI Research Program and the exciting future of research at the interface of ethics and genomics.